Early markers of cardiovascular injury in childhood leukaemia survivors treated with anthracycline chemotherapy

BACKGROUND: Cardiovascular disease (CVD) is the leading non-malignant cause of death in childhood cancer survivors. Heightened risk of CVD is often attributable to treatment with anthracycline chemotherapy. Anthracycline-mediated cardiac injury may lie latent for years following cessation of treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Long, Treya M., Marsh, Channa E., Dembo, Lawrence G., Watson, Philip, Wallman, Karen E., Walwyn, Thomas S., Choong, Catherine S., Naylor, Louise H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048057/
https://www.ncbi.nlm.nih.gov/pubmed/32154017
http://dx.doi.org/10.1186/s40959-019-0047-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048057/
https://www.ncbi.nlm.nih.gov/pubmed/32154017
http://dx.doi.org/10.1186/s40959-019-0047-4

Ejemplares similares